Gentox Bioservices Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 24-06-2024
- Paid Up Capital ₹ 2.73 M
as on 24-06-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.61 Cr
as on 24-06-2024
- Revenue 35.32%
(FY 2018)
- Profit -2.88%
(FY 2018)
- Ebitda 24.82%
(FY 2018)
- Net Worth 10.56%
(FY 2018)
- Total Assets 7.18%
(FY 2018)
About Gentox Bioservices
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.73 M.
The company currently has active open charges totaling ₹1.61 Cr.
Soumya Bondili and Mahendra Bondili serve as directors at the Company.
- CIN/LLPIN
U51220TG2005PTC046762
- Company No.
046762
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gentox Bioservices Private Limited offer?
Gentox Bioservices Private Limited offers a wide range of products and services, including Product Development Research, Toxicology Research, Dermatology Treatment Services, Dermatology Consultants.
Who are the key members and board of directors at Gentox Bioservices?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Bondili  | Director | 06-Jul-2005 | Current |
| Soumya Bondili | Director | 02-May-2022 | Current |
Financial Performance of Gentox Bioservices.
Gentox Bioservices Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 35.32% increase. The company also saw a slight decrease in profitability, with a 2.88% decrease in profit. The company's net worth Soared by an impressive increase of 10.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gentox Bioservices?
In 2018, Gentox Bioservices had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 26 Oct 2018 | ₹1.44 M | Open |
Others Creation Date: 31 Jan 2017 | ₹1.10 Cr | Open |
Indian Overseas Bank Creation Date: 29 Aug 2009 | ₹1.09 M | Open |
How Many Employees Work at Gentox Bioservices?
Unlock and access historical data on people associated with Gentox Bioservices, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gentox Bioservices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gentox Bioservices's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
